Best GLP-1 for Budget Under $150/Month (2026 Rankings)
There's a real difference between 'advertised $99 for month 1' and 'actually $146 every month.' Here's who delivers true sub-$150 pricing in 2026, and what you trade for those savings.
The Verdict
#1 Yucca Health ($146/mo) is the cleanest sub-$150 option. #2 Oral Wegovy 1.5mg ($149/mo through August 2026) for FDA-approved budget access. #3 Various promotional pricing (first-month discounts at MEDVi, Sprout) that bring initial costs below $150 but revert to higher rates. Pure budget category; know what you're trading for the savings.
The sub-$150/month GLP-1 tier is narrow but real. A legitimate compounded semaglutide prescription with consultation included can be had at this price point — but the providers that deliver it consistently are fewer than the marketing might suggest. This ranking is strictly about who delivers actual ongoing pricing under $150, not teaser rates that vanish after month one.
What "under $150" really means
The semaglutide API (active pharmaceutical ingredient) has a real cost. Compounding pharmacies have real operational costs. Licensed providers have real overhead. When you see prices below $100/month, be skeptical — those are usually promotional rates, loss-leader pricing, or the result of cost-cutting that affects quality.
True, sustainable pricing under $150/month requires the provider to operate at thin margins. Here's who does it, how, and what you trade.
Our rankings
Yucca Health
Yucca Health is the cleanest sub-$150 option on the market. $146/month includes consultation, medication, and shipping. No membership fees. No lock-in. No bait-and-switch pricing. You pay $146 month one and $146 month twelve.
What you get: Compounded semaglutide through a state-licensed 503A pharmacy. Asynchronous provider consultation. HSA/FSA eligible. Reliable shipping.
What you trade: Lighter clinical support than premium providers. No behavior-change coaching. Injectable only — no oral, drops, or lozenges. Mixed customer service reviews for non-clinical issues.
Oral Wegovy (1.5mg)
Oral Wegovy at the 1.5mg dose retails for $149/month through August 2026 (the 4mg dose jumps to $199 after August). This is genuinely FDA-approved medication priced in the compounded-tier range — an unprecedented value proposition for patients who want regulatory clarity without paying premium prices.
What you get: FDA-approved semaglutide in tablet form. Phase 3 clinical data. Regulatory oversight. Access via Ro, Hims, WeightWatchers, LifeMD, Sesame.
What you trade: Strict empty-stomach administration requirement. Daily dosing. Limited to lower doses at this price. Higher doses cost $299/mo or require the 12-month $249/mo subscription.
MEDVi (with promotional pricing)
MEDVi's introductory pricing of $99 for the first month brings initial costs well under $150 before reverting to $179/month. If you're trialing GLP-1s and don't yet know whether to continue, the first-month savings are real.
What you get: Month 1 at $99. Injectable + oral formats. Reasonable clinical depth. Month 2+ at $179.
What you trade: Ongoing rate ($179) is 23% above Yucca. Genuine budget value only for month 1.
Sprout Health (with promotional pricing)
Sprout Health's $199 introductory pricing doesn't land under $150 but is worth noting as the only platform with a price-lock guarantee — your monthly rate stays flat even as your dose increases. For patients planning long-term use, price stability has real value.
What you get: First-month $199, then $249 with price lock. Price-locked tirzepatide at $299. LegitScript accredited.
What you trade: Not truly sub-$150 after first month. Higher baseline pricing than competitors.
Insurance-covered brand-name
For insured patients, brand-name Wegovy or Zepbound through insurance often costs less than any compounded provider. If you haven't checked your coverage, do it first — the cheapest "sub-$150" option may actually be a $25 copay on FDA-approved medication.
What you get: FDA-approved medication at insurance copay rates. Usually $25–100/mo with manufacturer savings cards.
What you trade: Requires insurance coverage and prior authorization. Not available for uninsured patients.
What to avoid in the budget tier
- Prices below $99/month without explicit first-month promotional framing. Sustainable operations can't hit that price.
- Providers that won't disclose pharmacy partners. Legitimate budget providers are transparent about sourcing.
- Platforms without LegitScript accreditation or equivalent third-party verification.
- Sites that require upfront multi-month payment to lock in low prices, especially before you've received your first shipment.
- Overseas-only shipping or payment processors based in jurisdictions without pharmacy oversight.
The real question: is sub-$150 the right priority?
Saving $50–100/month on medication matters for tight budgets. But for many patients, the real decision is whether sub-$150 pricing represents genuine value or false economy. Consider:
- First-time users often benefit more from clinical support than from $50/month savings. Skipping the titration struggles of budget providers can be worth the premium.
- Experienced users who know the drill get the most from budget pricing. You don't need hand-holding you're not using.
- Patients with complex medical histories (T2D, multiple medications, pre-existing conditions) benefit from higher-touch providers regardless of cost.
Budget stacking: combining cheap medication with external support
If your budget is the constraint but you want stronger support than Yucca provides, a reasonable hybrid:
- Get medication from Yucca or oral Wegovy at $146–149/mo.
- Use free resources (Reddit r/Semaglutide, YouTube injection videos, GLP-1 communities) for peer support.
- See your PCP for labs and monitoring — covered by insurance even if medication isn't.
- Total cost: $146/mo + $0 for support ecosystem vs. $250/mo for premium bundled providers.
This works for self-directed patients who can navigate their own care.
Bottom line
Genuinely sub-$150/month GLP-1 access exists in 2026 — primarily through Yucca Health's $146/mo compounded semaglutide and oral Wegovy's $149/mo FDA-approved option. Both are legitimate. The right one depends on whether you prioritize regulatory approval (oral Wegovy) or compounded flexibility (Yucca). Avoid sub-$100 promises that rely on gimmicks or off-brand sourcing — the savings aren't worth the risks.